Get the Stockscreener App
162.72
0.02%
0.0685
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Cardinal Health Inc stock is traded at $162.72, with a volume of 504.84K.
It is up +0.02% in the last 24 hours and up +5.34% over the past month.
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
See More
Previous Close:
$162.79
Open:
$163.23
24h Volume:
504.84K
Relative Volume:
0.22
Market Cap:
$38.70B
Revenue:
$222.58B
Net Income/Loss:
$1.57B
P/E Ratio:
25.27
EPS:
6.4395
Net Cash Flow:
$1.85B
1W Performance:
+2.07%
1M Performance:
+5.34%
6M Performance:
+16.44%
1Y Performance:
+47.95%
1-Day Range:
$161.64
$163.40
1-Week Range:
$158.70
$164.07
52-Week Range:
$106.98
$168.44
Cardinal Health Inc Stock (CAH) Company Profile
Name
Cardinal Health Inc
Sector
Industry
Phone
(614) 757-3033
Address
7000 CARDINAL PLACE, DUBLIN, OH
Compare CAH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CAH
Cardinal Health Inc
|
162.90 | 38.68B | 222.58B | 1.57B | 1.85B | 6.4395 |
|
MCK
Mckesson Corporation
|
806.08 | 100.08B | 377.60B | 3.35B | 5.67B | 25.06 |
|
COR
Cencora Inc
|
333.06 | 65.07B | 316.65B | 1.91B | 1.14B | 9.7209 |
|
HSIC
Henry Schein Inc
|
62.85 | 7.67B | 12.50B | 314.00M | 421.00M | 2.44 |
|
AHG
Akso Health Group Adr
|
1.5876 | 871.91M | 2.22M | -5.63M | -1.68M | -0.24 |
Cardinal Health Inc Stock (CAH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-03-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Feb-05-25 | Upgrade | Jefferies | Hold → Buy |
| Jan-08-25 | Upgrade | TD Cowen | Hold → Buy |
| Jan-07-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Jan-06-25 | Upgrade | BofA Securities | Neutral → Buy |
| Dec-13-24 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Dec-04-24 | Resumed | Mizuho | Outperform |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Feb-09-24 | Upgrade | Argus | Hold → Buy |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Dec-14-23 | Initiated | Wells Fargo | Underweight |
| Jul-10-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Mar-31-23 | Initiated | Citigroup | Neutral |
| Feb-03-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Nov-04-22 | Upgrade | BofA Securities | Underperform → Neutral |
| Aug-22-22 | Resumed | Morgan Stanley | Overweight |
| May-26-22 | Downgrade | Barclays | Overweight → Equal Weight |
| May-18-22 | Upgrade | Evercore ISI | In-line → Outperform |
| Apr-12-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-01-22 | Resumed | Credit Suisse | Neutral |
| Aug-06-21 | Downgrade | Deutsche Bank | Buy → Hold |
| Aug-05-21 | Downgrade | BofA Securities | Buy → Underperform |
| May-10-21 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-08-21 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Nov-02-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Sep-25-20 | Upgrade | Deutsche Bank | Hold → Buy |
| Jul-20-20 | Upgrade | Guggenheim | Neutral → Buy |
| May-15-20 | Upgrade | UBS | Neutral → Buy |
| Apr-23-20 | Resumed | Credit Suisse | Neutral |
| Mar-20-20 | Upgrade | BofA/Merrill | Underperform → Buy |
| Feb-12-20 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Feb-07-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Dec-16-19 | Downgrade | Guggenheim | Buy → Neutral |
| Sep-12-19 | Initiated | Deutsche Bank | Hold |
| Aug-27-19 | Downgrade | Argus | Buy → Hold |
| Aug-20-19 | Upgrade | Guggenheim | Neutral → Buy |
| Apr-18-19 | Initiated | Guggenheim | Neutral |
| Jan-17-19 | Initiated | UBS | Neutral |
| Nov-16-18 | Downgrade | Leerink Partners | Outperform → Mkt Perform |
| Apr-24-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
| Apr-02-18 | Upgrade | Argus | Hold → Buy |
| Mar-08-18 | Initiated | Barclays | Equal Weight |
| Feb-27-18 | Resumed | BofA/Merrill | Underperform |
| Jan-05-18 | Initiated | Evercore ISI | In-line |
View All
Cardinal Health Inc Stock (CAH) Latest News
Cardinal Health Stock (CAH) Opinions on Upcoming Q1 2026 Earnings Release - Quiver Quantitative
Is Cardinal Health's (CAH) Move Into Advanced Therapy Logistics Shaping Its Investment Story? - Yahoo! Finance Canada
Will Cardinal Health Inc. stock outperform benchmarks2025 Market Outlook & Safe Capital Growth Tips - newser.com
Real time social sentiment graph for Cardinal Health Inc.Quarterly Trade Report & Precise Trade Entry Recommendations - newser.com
How Cardinal Health Inc. stock valuation compares with sectorJuly 2025 Levels & Risk Managed Investment Signals - newser.com
What To Expect From Cardinal Health’s (CAH) Q3 Earnings - TradingView
Is a relief rally coming for Cardinal Health Inc. holdersWeekly Stock Recap & Low Risk Entry Point Guides - newser.com
Will Cardinal Health Inc. stock see PE expansionProduct Launch & Low Risk Investment Opportunities - newser.com
What MACD signals say about Cardinal Health Inc.July 2025 Selloffs & Free Community Consensus Stock Picks - newser.com
Using R and stats models for Cardinal Health Inc. forecastingJuly 2025 News Drivers & Consistent Growth Stock Picks - newser.com
Trend analysis for Cardinal Health Inc. this weekGold Moves & Smart Swing Trading Techniques - newser.com
Cardinal Health upgraded by Evercore ISI to outperform - MSN
Is Cardinal Health Inc. (CLH) stock expanding market penetration2025 Analyst Calls & Free Community Supported Trade Ideas - newser.com
Strategies to average down on Cardinal Health Inc.Quarterly Performance Summary & Target Return Focused Stock Picks - newser.com
Does Cardinal Health Inc. show high probability of rebound2025 Support & Resistance & Real-Time Stock Movement Alerts - newser.com
Will Cardinal Health Inc. (CLH) stock enhance shareholder valueWeekly Profit Analysis & AI Forecasted Stock Moves - newser.com
Is Cardinal Health Inc. stock vulnerable to regulatory risksPortfolio Value Summary & AI Enhanced Market Trend Forecasts - newser.com
Has Cardinal Health Inc. formed a bullish divergenceAnalyst Upgrade & Weekly Hot Stock Watchlists - newser.com
Understanding Cardinal Health Inc.’s price movement2025 Price Targets & Low Risk Growth Stock Ideas - newser.com
When is the best time to exit Cardinal Health Inc.2025 Market Trends & Weekly Consistent Profit Watchlists - newser.com
Why Cardinal Health Inc. stock appeals to analystsPortfolio Value Report & Low Drawdown Trading Strategies - newser.com
Volatility clustering patterns for Cardinal Health Inc.July 2025 Technicals & Entry Point Strategy Guides - newser.com
How cyclical is Cardinal Health Inc. stock compared to rivalsTrade Volume Summary & Reliable Volume Spike Trade Alerts - newser.com
How Cardinal Health Inc. (CLH) stock trades under stagflationMarket Sentiment Review & Verified Technical Trade Signals - newser.com
Tools to monitor Cardinal Health Inc. recovery probabilityQuarterly Earnings Summary & Target Return Focused Stock Picks - newser.com
Published on: 2025-10-26 23:00:11 - newser.com
Can Cardinal Health Inc. recover in the next quarterWeekly Stock Report & Precise Buy Zone Identification - newser.com
Cardinal Health Inc Stock (CAH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.75%
1.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):